Elegen and GSK Sign Collaboration and Licensing Agreement to Further Develop Elegen’s Cell-Free DNA Production Technology

SOURCE: Business Wire

GSK has signed a collaboration & licensing agreement to leverage Elegen's cell-free DNA manufacturing technology in the development of GSK’s vaccines & medicines.